We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+9.66%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$26.6B
AUM Growth
+$7.03B
(+36%)
Cap. Flow
+$6.78B
Cap. Flow
% of AUM
25.47%
Top 10 Holdings %
Top 10 Hldgs %
27.09%
Holding
691
New
182
Increased
156
Reduced
161
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.51B |
| 2 |
Meta Platforms (Facebook)
META
|
+$681M |
| 3 |
Boeing
BA
|
+$467M |
| 4 |
Cisco
CSCO
|
+$399M |
| 5 |
Verizon
VZ
|
+$367M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Airlines
UAL
|
+$278M |
| 2 |
lululemon athletica
LULU
|
+$265M |
| 3 |
Microsoft
MSFT
|
+$244M |
| 4 |
Home Depot
HD
|
+$241M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$235M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.13% |
| 2 | Consumer Discretionary | 13.33% |
| 3 | Industrials | 12.74% |
| 4 | Healthcare | 10.35% |
| 5 | Communication Services | 7.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Achieve Life Sciences
ACHV
$697M
| $1.48M | 0.01% |
421,000
-50,000
| -11% | -$227K |
|
|
RNAM
477
DELISTED
Avidity Biosciences
RNAM
| $1.45M | 0.01% |
50,000
-25,000
| -33% | -$1.04M |
|
478
Intercontinental Exchange
ICE
$84.6B
| $1.42M | 0.01% |
9,514
-23,525
| -71% | -$3.73M |
|
|
UPB
479
Upstream Bio Inc
UPB
$413M
| $1.4M | 0.01% |
+85,000
| New | +$1.9M |
|
480
Unicycive Therapeutics
UNCY
$138M
| $1.39M | 0.01% |
175,000
-50,000
| -22% | -$277K |
|
481
Solid Biosciences
SLDB
$924M
| $1.39M | 0.01% |
346,371
| – | – |
|
482
Universal Health Services
UHS
$10.1B
| $1.38M | 0.01% |
7,679
-104,466
| -93% | -$21.3M |
|
483
CalciMedica
CALC
$10.4M
| $1.32M | 0.01% |
+372,256
| New | +$1.3M |
|
484
IN8bio
INAB
$9.75M
| $1.3M | ﹤0.01% |
168,776
+154,282
| +1,064% | +$1.35M |
|
|
DEC
485
Diversified Energy Company
DEC
$1.03B
| $1.3M | ﹤0.01% |
+77,353
| New | +$1.08M |
|
486
Skye Bioscience
SKYE
$19M
| $1.29M | ﹤0.01% |
456,163
-98,014
| -18% | -$410K |
|
487
CG Oncology
CGON
$6.79B
| $1.29M | ﹤0.01% |
+45,000
| New | +$1.54M |
|
|
PROF
488
Profound Medical
PROF
$274M
| $1.2M | ﹤0.01% |
+160,000
| New | +$1.23M |
|
|
LAC
489
Lithium Americas
LAC
$1.17B
| $1.19M | ﹤0.01% |
400,000
-400,000
| -50% | -$1.39M |
|
|
GB
490
DELISTED
Global Blue Group Holding
GB
| $1.17M | ﹤0.01% |
169,076
-100,000
| -37% | -$574K |
|
491
PACS Group
PACS
$7.46B
| $1.06M | ﹤0.01% |
80,612
-663,792
| -89% | -$17M |
|
492
CAMP4 Therapeutics
CAMP
$268M
| $1.04M | ﹤0.01% |
+200,000
| New | +$1.64M |
|
493
Traws Pharma
TRAW
$8.38M
| $1.04M | ﹤0.01% |
+116,714
| New | +$650K |
|
494
Savers
SVV
$1.84B
| $1.02M | ﹤0.01% |
100,000
| – | – |
|
|
ARTV
495
Artiva Biotherapeutics
ARTV
$549M
| $1.01M | ﹤0.01% |
100,000
| – | – |
|
496
Canadian Pacific Kansas City
CP
$80.7B
| $990K | ﹤0.01% |
+13,686
| New | +$1.05M |
|
497
PLAYSTUDIOS Inc
MYPS
$90.9M
| $930K | ﹤0.01% |
500,000
| – | – |
|
498
Modular Medical
MODD
$10.8M
| $913K | ﹤0.01% |
+22,222
| New | +$1.29M |
|
499
Owlet
OWLT
$160M
| $890K | ﹤0.01% |
200,000
| – | – |
|
|
BOLD
500
Boundless Bio
BOLD
$64.8M
| $870K | ﹤0.01% |
300,000
| – | – |
|
Similar funds
SAM
VIA
PPF
Alyeska Investment Group's Q4 2024 Portfolio in Review
As of Q4 2024, Alyeska Investment Group held 691 positions worth $26.6B, up 36% from $19.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Alyeska Investment Group deployed $6.78B of net new capital in Q4 2024, opening 182 new positions and adding to 156 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 5,926,710 shares worth $3.49B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was United Airlines, an estimated $278M trimmed.
- Alyeska Investment Group's largest Q4 2024 buy was iShares Core S&P 500 ETF: 5,926,710 shares worth $3.49B.
- Alyeska Investment Group added most to Meta Platforms (Facebook) in Q4 2024, an estimated $681M increase.
- Alyeska Investment Group's biggest Q4 2024 reduction was United Airlines, cutting an estimated $278M.
- Alyeska Investment Group fully exited Home Depot in Q4 2024, selling an estimated $241M.
- Alyeska Investment Group's ten largest holdings make up 27% of its $26.6B portfolio in Q4 2024.
- Alyeska Investment Group opened 182 new positions and closed 155 in Q4 2024.
- Alyeska Investment Group's portfolio value rose 36% quarter-over-quarter to $26.6B.
Based on Alyeska Investment Group's 13F filing for Q4 2024, filed 14 Feb 2025.